Most of the pharma units are failing in documentation, and validation processes, and many don't have full-fledged quality control laboratories.
There is no independent audit to investigate the cause of death and the regulator simply takes the word of the investigator.
Nidhi Saxena, founder of Karmic Lifesciences, a contract research organisation that was born in the bleak days of mid-2008, reveals what made her venture a success in four years.
According to Amitabh Arora, chief representative, Think London, "The agency will help Indian companies enter business agreements with 100-odd biotech and pharma companies and about 50 contract research organisations based in London besides arranging private equity from London-based PE firms.
WHRL was founded in 1990 by Nobel laureate Sir John Vane to fund the research works at William Harvey Research Institute, one of the leading centres in the world for pharmacological research.
Amgen, the world's largest biotechnology company, has entered India by opening a wholly owned subsidiary Amgen Technology in Mumbai.
Launches cloud-based version of solution to target mid-size clients in life sciences.
'There are different kinds of risk.' 'It is a very powerful value. Your ability to de-risk the risk is also as important for risk taking.'
Gamification has the potential to trigger immediate positive responses to learning that an organisation wishes to impart.
'Well begun is half done, today there are more hits than misses by the Modi government in its support towards science in India,' says Pallava Bagla.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances